PUBLIC AWARENESS RESEARCH 2005: REGULATION BIOTECHNOLOGY AUSTRALIA OCTOBER, 2005 Contents 1. Research context ............................................................................................ 1 Background .................................................................................................. 1 The nature of public attitudes .......................................................................... 1 Research design ............................................................................................ 2 2. Research findings ........................................................................................... 3 2.1 Responsibility for regulation ...................................................................... 3 2.2 Awareness of regulators ............................................................................ 3 2.3 Trust in regulators .................................................................................... 4 2.4 Opinions on rules and regulation ................................................................ 5 List of Figures Figure Figure Figure Figure Figure 1. 2. 3. 4. 5. Methodology ............................................................................................ 2 Responsibility for regulation (unprompted) .................................................. 3 Awareness of regulatory organisations ........................................................ 4 Trust in organisations to regulate ............................................................... 5 Agreement with statements regarding rules and regulations .......................... 6 List of Tables Table 1. Demographic differences in views on rules and regulations ............................. 6 Public Awareness Research 2005: Regulation 1. Research context Background Biotechnology Australia's Public Awareness Program aims to provide members of the community with the information they need to make more informed choices regarding the adoption of biotechnologies. Public attitudes are a crucial issue in the development of the Australian biotechnology sector, and public understanding of the science involved is important. However, there is as great a need for scientists (and policymakers) to understand the public's needs and concerns. Therefore, a need to understand the underlying drivers of community attitudes relating to biotechnology is crucial. The nature of public attitudes There has been a trend towards increasingly complex analysis of applications of technology from a simple risk-benefit analysis with some consideration of its ethical underpinnings, to a more considered analysis in terms of both the process of development and the outcomes (for individuals, industry and society) of the application. Five key factors have been identified that underlie the public's acceptance of applications of biotechnologies1. These are: Information — Information on what biotechnologies are and are not capable of, provided by a credible source. Regulation — Confidence that regulatory safeguards are in place to ensure the safety of the public and the environment. Consultation — A belief that the public has been appropriately consulted and given the opportunity for input into the development of biotechnology. Consumer choice — The ability of the consumer to either accept or reject each particular application of biotechnology. Consumer benefit — A perceived societal and individual benefit for each application. Finally, the rapid developments and advances in biotechnology mean that attitudes and acceptance relating to biotechnology, as well as the associations between them, are likely to change over time. It is important that these changes and explored and understood. To track these changes, research on behalf of Biotechnology Australia has been conducted every two years since 1999. This report provides details on the 2005 research conducted by Eureka Strategic Research. Social causes of public concerns about developments in biotechnology in Australia: Comparisons with other countries and lessons for Asia. By Craig Cormick. Accessed on the Biotechnology Australia website. 1 1 Public Awareness Research 2005: Regulation Research design A three-phase research program was employed, as illustrated in the following diagram. Figure 1. Methodology The CATI (Computer Assisted Telephone Interviewing) survey involved 1,067 respondents, between 18 and 75 years of age, which provided a 95% confidence interval of no more than ±3.0%. Survey respondents were selected from the electronic White Pages and were stratified by location (by state and territory, and then into capital and non-capital) to ensure that the sample was in proportion to the population. Broad age and gender quotas were also applied, within each location, once again to ensure the sample was proportionally representative. (More details on the research design are in the document Public Awareness Research 2005 Overview.) 2 Public Awareness Research 2005: Regulation 2. Research findings 2.1 Responsibility for regulation Respondents were asked to list (unprompted) the organisations that they believed were responsible for the regulation of gene technology in Australia. Results are shown in Figure 22. Figure 2. Responsibility for regulation (unprompted) The Federal Government (29.2%) was the source that was cited most often as being responsible for the regulation of gene technology in Australia, followed by the CSIRO (11.3%) and the Office of the Gene Technology Regulator (OGTR) (10.9%). A large proportion of respondents (43.1%) could not name any source that they believed to be responsible for regulation. 2.2 Awareness of regulators For each of the following five organisations involved in regulation, respondents (who had not previously named them unprompted) were asked whether they had heard of them. These results are displayed in Figure 33. It should be noted that an earlier survey question provided respondents with a list of potential sources of information about gene technology. It is possible that in their answers to the current question respondents were recalling the names of organisations that they had heard in the earlier question regarding information sources. These results should therefore be interpreted with caution. 2 3 Public Awareness Research 2005: Regulation Figure 3. Awareness of regulatory organisations Almost all respondents (93.5%) had heard of Australian Quarantine and Inspection Service (AQIS) and the majority (61.3%) was aware of Food Standards Australia and New Zealand (FSANZ). Less than a third had heard of the other organisations listed, with OGTR (22.8%) being the organisation of which the fewest respondents were aware. The group discussions revealed that, while many had not necessarily given any thought to the regulation of gene technology, they assumed and hoped that someone was looking out for the public. Few participants were aware of the current regulatory system, but many believed that "the government" was probably responsible for regulation. "Aren't the government the regulators?" In terms of what the regulation consisted of, participants cited legislation that was in place banning certain practices, such as cloning and growing GM crops. One of the more well-informed participants said: "At the moment there are strict controls over where it's one, how it's done and who can do it." 2.3 Trust in regulators For each organisation that respondents had at least heard of, respondents were asked whether they trusted that organisation to regulate gene technology in Australia. The results are shown in Figure 4. This graph shows the percentage of respondents who claimed that they had heard of each organisation. It should not be taken to imply any awareness of their regulatory role. 3 4 Public Awareness Research 2005: Regulation Figure 4. Trust in organisations to regulate The organisations that the greatest proportion of respondents trusted to regulate were the Australian Pesticides and Veterinary Medicines Authority (APVMA; 79.3%) and AQIS (79.2%). Approximately the same proportion of respondents said they trusted FSANZ (69.9%), OGTR (68.3%) and Biosecurity Australia (65.3%) to regulate gene technology. 2.4 Opinions on rules and regulation Agreement with statements regarding rules and regulations Survey respondents asked the extent to which they agreed with several statements about the control and regulation of gene technology in Australia. Results are displayed in Figure 5. 5 Public Awareness Research 2005: Regulation Figure 5. Agreement with statements regarding rules and regulations The majority (35% agreed and 43% agreed strongly) agreed that public consultation and participation improves regulation. A similar proportion (24% agreed and 27% agreed strongly) believed that farmers need to be GM-free to stay competitive, as believed that farmers need access to GM technology (31% agreed and 25% agreed strongly) in order to do so. A majority (35% agreed and 20% agreed strongly) also agreed that we have to accept some risk from GM for Australia to remain competitive. Many felt unable to comment on whether Australia's current rules are sufficient (25%) and whether they are being followed (30%). Table 3 outlines differences in respondents' agreement with the statements above based on demographic variables. In general, older, female and those less educated had more conservative views in terms of rules and regulations. Table 1. Demographic differences in views on rules and regulations The current rules in Australia are sufficient The current rules in Australia are followed by those working on gene technology We have to accept some degree of risk from gene technology if it enhances Australia's economic competitiveness Public consultation and participation improves the regulation of gene technology Australian farmers need access to gene technology to stay internationally competitive Less likely to agree More likely to agree Older Younger Without children in household With children in household Older Females English speaking background Younger Males NonEnglish speaking background Older Younger Females Males 6 Public Awareness Research 2005: Regulation Australian farms and foods need to be free of genetically modified organisms to stay internationally competitive Less likely to agree More likely to agree Younger More educated Males Older Less educated Females Attitudes towards rules and regulations Throughout the discussions, participants made frequent reference to the need for gene technology to be "controlled" or regulated. For example, on participant said in relation to stem cell research: "As long as they're controlled — some sort of body that we can trust and that you've heard enough about." Regulation was considered by participants to be necessary, but not sufficient. That is, it was generally thought that, if gene technologies were to be pursued, regulation could offer the general public some level of protection. However, it was certainly not considered to be any guarantee of safety. Where participants felt that an application of gene technology was worth pursuing, despite potential risk, regulation was seen to provide additional reassurance. However, in some cases, participants felt that the risks posed or potential for misuses was so great, that regulation offered little comfort. They felt that, in the unlikely event that something went wrong, there was simply too much to lose. "There's just too much scope for things to go wrong." "There will always be people who will try and push the boundaries of the regulation." In cases where participants disapproved of the technology outright (e.g. on religious grounds), regulation offered no comfort. In discussions, two aspects of regulation were discussed — the making of the rules and the enforcing of them. These are each discussed in turn below. Some participants mentioned that politicians were not in an appropriate position to act as decision-makers in areas such as gene technology. It was deemed important by participants that experts, who understand the science involved and are aware of public opinion, advise politicians on regulatory issues. "Politicians are not experts. They can only act upon advice." There was support for efforts by the government to conduct public consultation, to ensure the public is informed and their views canvassed. Nevertheless, many individuals admitted that they did not have the inclination to participate in such a process. Indeed, most participants felt that they were not equipped to make, nor wanted to be responsible for, decisions that impact upon the whole population. A few participants even expressed concern that decision makers may get caught up in uninformed public opinion. Generally, participants in the research felt they would be satisfied with having the opportunity to decide for themselves and their families whether or not to adopt specific applications of gene technology. For example, provided they had enough information, most participants were reasonably content to deciding for themselves whether they purchased GM foods or GM-free alternatives. 7 Public Awareness Research 2005: Regulation There did not appear to be a pressing desire for citizen-led regulation of biotechnology, provided decision-makers understood, and took into account, the views of the public. Participants emphasised that the process of developing appropriate rules should be transparent, to allay concerns that they were overly influenced by those in a position to profit from any particular outcome. For example, participants were concerned that if multinationals were able to sway politicians decisions, regulation of the technology were controlled by chemical companies, regulation of gene technology would be driven by their motivations of corporate greed and power, rather than by what was likely to be in the best interests of the public. Nevertheless, participants recognised that despite best efforts, whoever made the rules there was the potential for mistakes to be made. Thus, while most participants would support rules based on the above-mentioned model, they recognised that it was not infallible. "They are only human, they make mistakes. Look at all the approved drugs coming onto the market . . . 5, 10, 20 years later you find out about them [their adverse effects]." They were also aware that, due to the diversity of beliefs about gene technology in the Australian population, no one decision or set of rules would be satisfactory to all. Participants also recognised that rules are only as beneficial as the manner in which they are enforced. "It depends on who's enforcing the rules and how stringently they make sure they're sticking to them.. .cause you can make all the rules but you might not stick to them." Some participants perceived the need for mechanisms to be implemented to "keep the regulator honest". Many thought the regulator(s) should be answerable to consumer bodies and the general public. Some wanted to see regulatory responsibility shared amongst a number of organisations. "I would want one that splintered off and answered to various departments and governing bodies because you can get very in-house and tell people what you want them to know." Participants also felt that, in order for rules to be policed effectively, the regulators would need sufficient expertise (as high as the scientists themselves) to ensure complete awareness and understanding of the technologies that were being pursued. There was also the recognition that regulators would need access to sufficient resources if they were to be able to do their job properly. However, some participants appeared to resent any resources that such a task would demand, believing it preferable for them to be allocated to areas perceived to be of more importance (e.g. education and health). 8